David E. Nix
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 29
-
- Antibiotic Use and Resistance 15
- Pharmacology top 0.1%
- Antibiotics Pharmacokinetics and Efficacy 66
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 13
- Epidemiology top 0.5%
- Pneumonia and Respiratory Infections 18
- Fungal Infections and Studies 13
-
- Antifungal resistance and susceptibility 16
- Antimicrobial Resistance in Staphylococcus 11
- Co-authors
- Jerome J. SchentagAlan ForrestMary C. BirminghamCharles H. BallowCharles A. PeloquinThomas F. GossAhmad AljadaClaude Bohuon
- Journals
- Antimicrobial Agents and Chemotherapy (24 papers)Annals of Pharmacotherapy (15 papers)Open Forum Infectious Diseases (10 papers)
- Partner nations
- United StatesSaudi ArabiaAustralia
In The Last Decade
David E. Nix
135 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Molecular Medicine 1.4k
- Applied Microbiology and Biotechnology 483
- Pharmacology 2.7k
- Clinical Biochemistry 564
- Epidemiology 2.7k
Countries citing papers authored by David E. Nix
This map shows the geographic impact of David E. Nix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Nix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Nix more than expected).
Fields of papers citing papers by David E. Nix
This network shows the impact of papers produced by David E. Nix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Nix. The network helps show where David E. Nix may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David E. Nix, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 10 | |
| 12 | 2021 | 0 | |
| 13 | 2020 | 31 | |
| 14 | 2020 | 21 | |
| 15 | 2004 | 39 | |
| 16 | The Audit Oversight Function in Municipalities of Greater Than 100,000 Population When an Audit Committee Is Not Used | 1996 | 2 |
| 17 | Pharmacodynamic interactions of ciprofloxacin , piperacillin , and piperacillin/tazobactam in volunteer subjects | 1994 | 1 |
| 18 | Focus on itraconazole: A broad-spectrum antifungal agent for treatment of blastomycosis and histoplasmosis | 1993 | 2 |
| 19 | 1992 | 28 | |
| 20 | 1991 | 126 |
About David E. Nix
David E. Nix is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Pharmacology, having authored 140 papers that have together received 5.8k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (66 papers), Antibiotic Resistance in Bacteria (29 papers), Pneumonia and Respiratory Infections (18 papers), Antifungal resistance and susceptibility (16 papers), Antibiotic Use and Resistance (15 papers), Bacterial Identification and Susceptibility Testing (13 papers), Fungal Infections and Studies (13 papers) and Antimicrobial Resistance in Staphylococcus (11 papers). The work is most often cited by research in Molecular Medicine (1.4k citations), Applied Microbiology and Biotechnology (483 citations) and Pharmacology (2.7k citations). David E. Nix has collaborated with scholars based in United States, Saudi Arabia and Australia. Frequent co-authors include Jerome J. Schentag, Alan Forrest, Mary C. Birmingham, Charles H. Ballow, Charles A. Peloquin, Thomas F. Goss, Ahmad Aljada, Claude Bohuon, Paresh Dandona and Michael F. Wilson. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Annals of Pharmacotherapy, Open Forum Infectious Diseases, American Journal of Health-System Pharmacy and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.